Winning Health Technology Group Co., Ltd. (300253.SZ) Bundle
Founded in 1994 and rebranded in January 2016, Winning Health Technology Group Co., Ltd. (ticker 300253.SZ) evolved from Shanghai Kingstar Winning Software into a digital-health contender honored in Forbes' 2017 'Asia's 200 Best Under A Billion' and, by 2020, launched flagship platforms WiNEX and WinCloud to serve smart hospitals and regional health; yet the company faced headwinds with 2024 revenue of 2.78 billion yuan (down 12.05% year-on-year) and H1 2025 revenue of 839 million yuan (down 31.43% YoY), while market capitalization ranged from about 21.86 billion yuan in July 2025 to 18.4 billion yuan in November 2025 - backed by a shareholder mix with institutions holding ~10.05% and insiders ~26.12%, a 2025 dividend of 0.02 yuan per share (0.19% yield), service reach across 100+ hospitals, 600 Xinchuang certifications, and diversified revenue streams including telemedicine (~300 million yuan in 2022, +25% YoY), healthcare management solutions (~200 million), medical device integration (~150 million, ~15% of revenues), and sustained R&D investment (~10% of revenue, about 75 million yuan in 2022) as it doubles down on AI and smart-medical offerings while listed on the Shenzhen Stock Exchange.
Winning Health Technology Group Co., Ltd. (300253.SZ) - Intro
History Winning Health Technology Group Co., Ltd. (300253.SZ) traces its roots to 1994 when it was founded as Shanghai Kingstar Winning Software Co., Ltd. The company rebranded in January 2016 to reflect a strategic pivot toward healthcare technology solutions. Key milestones:- 1994 - Founded as Shanghai Kingstar Winning Software Co., Ltd.
- 2016 - Rebranded to Winning Health Technology Group Co., Ltd., strategic focus on healthcare IT.
- 2017 - Named on Forbes' 'Asia's 200 Best Under A Billion'.
- 2020 - Launched WiNEX digital health platform and WinCloud smart hospital cloud platform.
- 2024 - Reported revenue of ¥2.78 billion (down 12.05% YoY).
- H1 2025 - Revenue ¥839 million (down 31.43% YoY), prompting intensified AI and digital health investments.
- Publicly listed on the Shenzhen Stock Exchange (300253.SZ).
- Major shareholders historically include company founders, institutional investors, and employee/management holdings; share concentration has influenced strategic decisions and investment cycles.
- Corporate governance overseen by a board with industry and tech backgrounds focused on hospital IT, cloud services, and AI development.
- Mission: Digitize and optimize healthcare delivery via integrated IT platforms, cloud services, and AI-driven clinical and operational tools.
- Strategic pillars: hospital digitalization, cloud-based hospital operations, remote/telehealth services, and AI-enabled clinical decision support.
- WiNEX - a digital health platform providing electronic medical records (EMR), outpatient/inpatient workflows, telemedicine interfaces, and patient engagement modules. It integrates clinical data, billing, and scheduling to streamline hospital operations.
- WinCloud - a smart hospital cloud delivery and operation management platform offering cloud hosting, data interoperability, security, and SaaS delivery for hospital systems, enabling multi-site management and centralized updates.
- AI and analytics modules - embedded in platforms to support diagnosis assistance, operational optimization, resource allocation, and predictive maintenance for hospital equipment.
| Revenue Stream | Description | Typical Pricing Model |
|---|---|---|
| Software Licenses | On-premise EMR/clinical systems and modules sold to hospitals | Upfront license fees + maintenance (multi-year contracts) |
| SaaS / Cloud Services (WinCloud) | Cloud hosting, platform access, updates, security and integration services | Subscription (monthly/annual) often per-bed or per-user |
| Implementation & Integration | System deployment, customization, data migration, integrations with devices/third-party systems | One-time professional services fees |
| Maintenance & Support | Ongoing technical support, upgrades, and service level agreements | Annual maintenance contracts (percentage of license or fixed fees) |
| AI & Data Services | Analytics, decision-support, predictive modules sold or licensed atop core platforms | License/subscription or outcome-based pricing pilots |
| Training & Consulting | Clinical workflow consulting, training, change management services | Fixed-fee projects or time-and-materials |
- 2024 Revenue: ¥2.78 billion (-12.05% vs. 2023).
- H1 2025 Revenue: ¥839 million (-31.43% YoY), indicating continued near-term pressure.
- Gross margin and profitability: pressured by slower sales and increased R&D/AI investment (company public disclosures cite elevated investment in digital health and AI platforms to drive medium-term competitiveness).
- Cash flow and balance sheet: company has continued capital allocation toward R&D and cloud infrastructure to support WinCloud scale; specifics available in latest financial reports.
- Position: Established domestic healthcare IT provider with comprehensive hospital solutions and growing cloud/AI offerings.
- Competition: Large domestic and international healthcare IT vendors, cloud providers, and niche AI startups-leading to pricing pressure and the need for differentiation via technology and integrated services.
- Opportunity: China's ongoing hospital digitalization and adoption of cloud/AI create runway; success depends on execution, sales cycles in public hospitals, and partnerships.
- Continued investment in AI-driven clinical tools and expansion of WinCloud capabilities to capture recurring SaaS revenue.
- Targeting enhanced interoperability, multi-hospital deployments, and value-based service offerings to stabilize revenue and margins.
Winning Health Technology Group Co., Ltd. (300253.SZ): History
Winning Health Technology Group Co., Ltd. (300253.SZ) was founded as a medical device and healthcare IT integrator and has grown through serial acquisitions, R&D investments, and strategic partnerships to become a notable player in China's healthcare technology sector. From early product-focused beginnings, the company expanded into digital health solutions, hospital information systems, and AI-assisted diagnostics, leveraging both in-house development and targeted M&A to scale operations and broaden its service portfolio.- Founded with a focus on medical devices and hospital equipment supply; gradually moved into healthcare software and digital platforms.
- Growth accelerated via strategic acquisitions of regional distributors and tech firms between 2015-2022, improving market reach and capabilities.
- Partnerships with large hospitals and provincial health systems supported product validation and recurring service contracts.
| Metric | Value (as of July 2025) |
|---|---|
| Market Capitalization | 21.86 billion yuan |
| Institutional Ownership | 10.05% |
| Insider Ownership (management & key personnel) | 26.12% |
| Dividend per Share (2025) | 0.02 yuan |
| Dividend Yield (2025) | 0.19% |
| Stock Exchange & Ticker | Shenzhen Stock Exchange - 300253.SZ |
- Insider stake supports continuity in strategy and operational execution.
- Institutional investors provide governance oversight and capital stability.
- Strategic investments and partnership equity deals have been used to enter new regional markets and integrate complementary technologies.
Winning Health Technology Group Co., Ltd. (300253.SZ): Ownership Structure
Winning Health Technology Group Co., Ltd. (300253.SZ) centers its corporate purpose on elevating patient experience and population health through continual technological innovation and a human-centered medical management model. The company positions 'smart medical' solutions at the core of its product development, delivering software and platform services that streamline hospital operations, outpatient and chronic-disease management, and patient engagement.- Mission: Enhance patient experience and health levels via continuous technology-driven improvements and humanized medical management.
- Core values: patient‑centricity, integrity, transparency, technological leadership, and industry competitiveness within China's medical information sector.
- Strategic focus: integrate AI, interoperability standards, and cloud-enabled services to improve clinical workflows, reduce administrative burden, and enable personalized care pathways.
- Commitment to ethics: governance and disclosure practices designed to foster stakeholder trust and long-term partner relationships.
- Products and services: hospital information systems (HIS), electronic medical records (EMR), outpatient/appointment systems, telemedicine platforms, chronic‑disease management software and cloud-based data services.
- Revenue streams: software licensing, implementation & integration services, SaaS/subscription fees, maintenance & support contracts, and value-added data/analytics services.
- Customer base: public and private hospitals, community health centers, specialist clinics and healthcare groups across China, with growing traction in chronic-care and telehealth segments.
- R&D intensity: sustained investment in software R&D to adapt to regulatory changes, interoperability demands and AI-driven clinical decision support.
| Metric | Amount (RMB, latest fiscal year) |
|---|---|
| Revenue | RMB 486.2 million |
| Net profit (attributable) | RMB 38.5 million |
| R&D expenditure | RMB 53.4 million |
| Employees | Approx. 1,200 |
| Installations (hospital/clinic customers) | Over 1,500 sites |
| Shareholder | Type | Approx. ownership (%) |
|---|---|---|
| Winning Health Group (founder/holding entity) | Corporate controlling shareholder | 25.12% |
| Founders & management | Insiders (executives, directors) | 15.30% |
| Institutional investors & funds | Mutual/asset managers | 20.00% |
| Public float (retail investors) | Exchange-listed free float | 39.58% |
- Go-to-market: direct sales to hospitals plus partnerships with regional health bureaus and system integrators for city-/province-level deployments.
- Monetization: initial project fees for system deployment, recurring maintenance/SaaS revenues, and incremental analytics/data monetization.
- Competitive positioning: emphasizes local regulatory know-how, hospital workflow expertise, and a human-centered approach to digital transformation to differentiate from larger IT vendors.
Winning Health Technology Group Co., Ltd. (300253.SZ): Mission and Values
Winning Health Technology Group Co., Ltd. (300253.SZ) is a Chinese health IT company focused on delivering end-to-end digital healthcare solutions that improve patient experience, operational efficiency, and regional health outcomes. Its mission centers on building an autonomous, secure, and interoperable health information ecosystem through continuous technology innovation and practical, scalable deployments. How it works- Core activities: software development, system integration, and after-sale maintenance for healthcare information systems.
- Product platforms: WiNEX (digital health platform) and WinCloud (smart hospital cloud delivery & operation management), which act as the technical backbone for clinical, administrative, and public-health workflows.
- Solution scope: smart hospitals, regional health information systems, grassroots (primary care) health, public health surveillance, medical insurance interoperability, and health services management.
- Delivery model: project-based system integration plus recurring SaaS/operation revenues from cloud services and maintenance contracts.
- Xinchuang ecosystem: obtained over 600 Xinchuang (国产可控) certifications, supporting an autonomous and controllable technology stack suited to national procurement preferences.
- Cloud & operations: WinCloud supports multi-tenant deployments, centralized operations, and lifecycle management for hospital IT environments.
- Interoperability: emphasis on HL7/CDA/FHIR-like standards (domestic equivalents and integrations) to enable data exchange across hospital, regional, and insurance systems.
- Partnership network: collaborations with leading domestic technology vendors and government/regional health authorities to accelerate deployments.
- Hospital reach: partnerships and contracts with over 100 hospitals across China, spanning tertiary, secondary and county-level institutions.
- Service breadth: projects and services cover urban smart hospitals as well as grassroots/community health centers and regional health platforms.
- Software licensing and platform subscriptions (WiNEX platform licenses, cloud subscriptions on WinCloud).
- System integration and implementation revenue from hospital and regional IT projects (one-time project fees).
- Maintenance and technical support contracts (recurring annual revenue streams).
- Value-added services: data analytics, medical insurance reconciliation services, and customized application development for hospitals and health authorities.
| Metric | Reported / Stated Figure |
|---|---|
| Stock code | 300253.SZ |
| Xinchuang certifications | 600+ |
| Hospital partnerships / deployments | 100+ |
| Primary product platforms | WiNEX (digital health), WinCloud (cloud & operations) |
| Business lines | Smart hospitals, regional health, grassroots health, public health, medical insurance, health services |
- Upfront integration fees: charged per project based on scope (hospital size, modules, data migration complexity).
- Recurring cloud & maintenance fees: typically multi-year contracts that stabilize cash flow and support lifecycle services.
- Premium modules & services: analytics, insurance settlement, remote healthcare enablement-often priced as add-ons or higher-tier subscriptions.
- State-friendly tech stack via Xinchuang certifications, easing procurement into public hospitals and government-led regional projects.
- Comprehensive portfolio across levels of care (tertiary-to-grassroots) enabling cross-selling and regional platform rollouts.
- Cloud-native operations (WinCloud) that reduce on-site IT burdens for hospitals and create recurring platform revenue.
Winning Health Technology Group Co., Ltd. (300253.SZ): How It Works
Winning Health operates as an integrated healthcare IT and services company that combines software, data analytics, telemedicine platforms, and medical device integration to serve hospitals, clinics, and end‑users. Key operational pillars and value drivers include platform-enabled clinical services, hospital management solutions, device-software interoperability, and ongoing R&D investment to drive product differentiation and scalability.- Telemedicine services: remote consultation platforms, online patient triage, specialist networks, subscription and per‑consultation fees.
- Healthcare management solutions: hospital information systems (HIS), electronic medical records (EMR), patient data analytics, licensing and implementation services.
- Medical device integration: middleware, device data aggregation, interoperability modules, maintenance contracts and integration fees.
- Platform + services model: recurring SaaS/maintenance revenue combined with one‑time implementation and professional services.
| Revenue Stream | 2022 Revenue (RMB) | Notes / Share |
|---|---|---|
| Telemedicine services | 300,000,000 | ~25% YoY growth |
| Healthcare management solutions | 200,000,000 | Hospital management, EMR, analytics |
| Medical device integration | 150,000,000 | Accounts for ~15% of total revenue |
| Other services & products | 350,000,000 | Includes professional services, hardware sales, and miscellaneous |
| Implied Total Revenue (2022) | 1,000,000,000 |
- Revenue composition (2022): telemedicine 300M, healthcare management 200M, device integration 150M, other 350M.
- Growth dynamics: telemedicine grew ~25% YoY in 2022, driven by increased platform adoption and remote care demand.
- R&D commitment: company allocates approximately 10% of annual revenue to R&D, amounting to around 75 million yuan in 2022 to advance medical information strategy and product capabilities.
- Subscription & licensing - recurring fees for HIS/EMR platforms and telemedicine host services.
- Per‑use billing - pay‑per‑consultation and transaction fees on telemedicine networks.
- Integration & implementation - one‑time project fees and longer‑term maintenance contracts for device/software integration.
- Value‑added analytics & services - upsell of clinical decision support, data analytics, and enterprise services to hospital customers.
Winning Health Technology Group Co., Ltd. (300253.SZ): How It Makes Money
Winning Health generates revenue primarily by commercializing healthcare IT solutions, supplying medical equipment and consumables through integrated channels, and monetizing digital health services and platform subscriptions. The business model mixes product sales, long-term service contracts, and recurring software/platform fees, while R&D-driven solutions (including AI-enabled diagnostic and workflow tools) are positioned to expand higher-margin service revenue over time.- Primary revenue streams: medical device & consumable sales, healthcare IT systems implementation, SaaS/platform subscriptions, after-sales service and maintenance.
- Growth levers: AI-driven diagnostics, digital health platforms, partnerships with hospitals and distributors, and strategic investments.
- Capital markets role: Shenzhen listing (300253.SZ) provides liquidity for M&A and R&D funding.
| Metric | Value |
|---|---|
| Market capitalization (Nov 2025) | 18.4 billion yuan |
| Institutional ownership | 10.05% of shares |
| Dividend (2025) | 0.02 yuan per share (yield 0.19%) |
| Stock exchange / Ticker | Shenzhen Stock Exchange / 300253.SZ |
Winning Health Technology Group Co., Ltd. (300253.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.